Columbus, Ohio - Barbara Kunz, Battelle’s President of the Health and Life Sciences Global Business, was named as one of nine public members to The Ohio State University’s James Cancer Hospital Board Jan. 7. The board also has six ex-officio members as established by OSU’s Board of Trustees for the oversight of strategic initiatives, patient care services, and financial performance of the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Kunz joined six other new public members to the specialized board, which includes people with business and legal expertise, knowledge of healthcare delivery and the mission of the university’s academic medical center.
Kunz is accountable for Battelle’s portfolio of businesses and capabilities for government and commercial clients within the pharmaceutical, biotechnology, medical devices and diagnostics, public and environmental health, and agri/food industries. In addition, she is responsible for the relationship between Battelle and the United States Department of Health and Human Services agencies, such as the Centers for Disease Control, the National Institutes of Health, the National Institute for Allergy and Infectious Diseases, and the National Institute of Environment Health Sciences, as well as the Environmental Protection Agency.
She joined Battelle from Fisher Scientific International, where she held the position of Senior Vice President and General Manager for Fisher Biosciences.
Kunz has a B.S. in Chemistry and in Biology from Thiel College, an M.S. in Polymer Science from the University of Akron and qualified in the International Executive Program, INSEAD in Fontainebleau, France.
Battelle’s Global Health and Life Sciences business delivers a comprehensive set of R&D services to solve complex challenges for government health agencies and medical device, biotechnology, and pharmaceutical firms. Including its national laboratories, Battelle’s health and life sciences-research impacts some of the most critical problems in human health through advances in medical devices, pharmaceuticals, public health, and next-generation diagnostics and therapeutics.
As the world’s largest, independent research and development organization, Battelle provides innovative solutions to the world’s most pressing needs through its four global businesses: Laboratory Management, National Security, Energy Technology, and Health and Life Sciences. It advances scientific discovery and application by conducting $5.2 billion in global R&D annually through contract research, laboratory management and technology commercialization. Headquartered in Columbus, Ohio, Battelle oversees 20,400 employees in more than 130 locations worldwide, including seven national laboratories which Battelle manages or co-manages for the U.S. Department of Energy and the U.S. Department of Homeland Security and two international laboratories—a nuclear energy lab in the United Kingdom and a renewable energy lab in Malaysia.
Battelle also is one of the nation’s leading charitable trusts focusing on societal and economic impact and actively supporting and promoting science and math education.
Media contacts:
Katy Delaney at (614) 424-7208, delaneyk@battelle.org
T.R. Massey at (614) 424-5544, masseytr@battelle.org
